Navigation Links
Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse

Prevalence of Alcohol Abuse Among ADHD Patients Nearly Triple That of General Population, Affecting Approximately 1 Million People

INDIANAPOLIS, May 23, 2007 /PRNewswire-FirstCall/ -- Data from a recent clinical study showed Strattera(R) (atomoxetine HCl) improved symptoms of Attention- Deficit/Hyperactivity Disorder (ADHD) in patients with comorbid alcohol abuse disorder, suggesting ADHD can be treated safely and effectively with Strattera in patients with both disorders. Results from the 12-week study were presented today at a major medical meeting of psychiatrists.

The study was designed to test the hypothesis that Strattera is superior to placebo in the treatment of ADHD symptoms and prevention of relapse of alcohol abuse in adult patients with both ADHD and comorbid alcohol abuse disorder who were recently abstinent.

"ADHD is present in at least one-quarter of adults with alcohol abuse or dependence. Treating ADHD in adults with co-occurring alcohol abuse can be challenging, and up until now, no data have been available to help us know how to treat these patients. Often the first course of action is to treat the alcohol problem first, then later the ADHD," said study author Timothy E. Wilens, M.D., director of substance abuse services in the Pediatric Psychopharmacology Clinics at Massachusetts General Hospital and associate professor of psychiatry at Harvard Medical School in Boston. "While additional studies are needed, this study is encouraging because it is the first to show that ADHD can be treated safely and effectively with Strattera in patients with ADHD and very recent alcohol abuse."

Results of the study of 147 adults who met full DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders) criteria for ADHD and comorbid alcohol abuse, showed that Strattera was superior to placebo in the reduction of ADHD symptoms as measured by the ADHD Investigator Symptom Rating Scale
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
(Date:11/25/2009)...Newswire-FirstCall/ -- American Scientific Resourc...ased to announce that they have opened a regional ...ghai, China. ,, ASR has been able to secure a l... the development and production of current and fut...ults to be distributed and sold globally. Current...
(Date:11/25/2009)...ewswire-FirstCall/ -- Hologic, Inc. (Hologic or th...manufacturer and supplier of premium diagnostics, ...cated to serving the healthcare needs of women, is...ety of North America (RSNA) at McCormick Place in ...ighlight our new SecurView(®) DX multimodalit...
(Date:11/25/2009)...ewswire-FirstCall/ -- ERT (Nasdaq: ERES ), announ...y,s President and CEO, and Keith Schneck, the Comp...led to present at the 21st Annual Piper Jaffray He... 2009 in New York City, New York. ,, Interested...he Company,s corporate website at http://www.ert....
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 1Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 2Actuaries Urge Need for Risk Management and Continuity Planning With H1N1 Pandemic 48724 3Purity Products Partners with Leading Vitamin D Expert to Create Next Generation D3 Complex 48723 1Purity Products Partners with Leading Vitamin D Expert to Create Next Generation D3 Complex 48723 2Aviation Law Expert Offers Guidance on How Families of Air France Flight 447 May Seek Compensation from Airline 48721 1Aviation Law Expert Offers Guidance on How Families of Air France Flight 447 May Seek Compensation from Airline 48721 2
...ity in Evaluating Drug,Efficacy; Dr. H. Bryan Brew...,PLEASANTON, CA, Mar 30, 2007 (MARKET WIRE via COM... LIPD) Dr. H. Bryan Brewer, Jr.,Chief Scientific ...he wide range of presentations at the recent Ameri...eans that the rationale for HDL,being the next, mo...
...ire-FirstCall/ --,Wyeth Pharmaceuticals, a divisio...beck A/S presented clinical study,results on bifep...ek. Safety analyses suggest bifeprunox, an investi...th schizophrenia, was,associated with a favorable ...ddition, increases in weight occurred in patients,...
Other Medicine Technology:Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 2Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 3Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 4Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 5Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 6
(Date:11/26/2009)... too big or too heavy can lead to strains or worse...-- There may be nothing wrong with stuffing your t...do the same thing with your suitcase as you pack f...e treated in 2008 in U.S. hospital emergency rooms...lities for luggage-related injuries, such as muscl...
(Date:11/26/2009)... No more letters from the North Pole, T... text messages from Santa , ...ase operational efficiencies at the North Pole San... children all over the globe informed of his Chris...a’s research department have identified a la...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a...rolina, today announced the expansion of its servi...entist, Dr. Doug Macmillan. , ...ntal is pleased to announce that Dr. Doug Macmilla...mpleted an additional advanced training seminar. ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering fr... of Yaz and Yasmin birth control pills who have su...olism, Stroke, Heart Attack or other related cardi...can call toll free at 1-800-856-6405 or go to the ...and fill out an online case evaluation form. , ...
(Date:11/25/2009)...ANSAS CITY, Mo., Nov. 25 The Bartl...he nation,s largest medical clinic on Dec. 9-10, w...ssive free clinics for uninsured people. ,, "Th...iggest one yet, because it will extend over two da...tead of over a weekend," Sheri Wood, executive dir...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...5 As one of Governor Crist,s,chosen health care i...da plan,Blue Cross and Blue Shield of Florida (BCB...ailable to uninsured Floridians. These plans are a...prnh/20000427/BLUELOGOA ) , BCBSF is offering...
... sudden cardiac arrest , , MONDAY, Jan. 5 ... beating on July 20, 2007. Just like that. , "I wa...rsity, doing normal laps," recalled Babcock, who w...rt stopped on July 20, 2009. "I was sitting at my ...
... When Lamont Christian,returned from war, he often...stian found himself living in a homeless shelter, ...ds. , He went to the VA Ann Arbor Healthcare S... problems. Now, he wants others,to learn from his ...
... leader in quality laminate,casework is aiming to ...Inc.,s new "CaseQ" program is designed to offer cu... in CaseQ stands for "quick ship," according to Ca...dard shipping from our facility is guaranteed in f...
...n. 5 Based on its recent analysis,of the cardiova...izes Toshiba,America Medical Systems with the 2008...lthcare Innovation. The company has launched a var...cardiography a step ahead of plain 4D imaging by a...
...ife Sciences (OTC Bulletin Board: RBCL) announced... W. Price, to CEO effective January 1, 2009. Compa...will remain as chairman of the board of directors....roducts, is growing domestically and international...
Other Medicine News:Health News:Blue Cross and Blue Shield of Florida Launches Cover Florida Plans for the Uninsured 2Health News:When the Heart Stops Beating 2Health News:U-M Health Minute: Today's Top Health Issues and Medical Research 2Health News:U-M Health Minute: Today's Top Health Issues and Medical Research 3Health News:CaseQ Quick Ship Casework Program Announced Today 2Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 2Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 3Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 4Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 3
Optical Urethrotome for Telescope 1.9 mm
Optical Urethrotome for Telescope 2.7 mm
Optical Mini Urethrotome
Stryker Cystoscopes
Medicine Products: